Global Infant Transcutaneous Jaundice Meter Market Growth 2026-2032
Description
The global Infant Transcutaneous Jaundice Meter market size is predicted to grow from US$ 103 million in 2025 to US$ 116 million in 2032; it is expected to grow at a CAGR of 2.1% from 2026 to 2032.
The core drivers of the development of the transcutaneous bilirubin meter industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.
In 2024, global Infant Transcutaneous Jaundice Meter reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.
Infant Transcutaneous Jaundice Meter are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.
Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.
The upstream core components of Infant Transcutaneous Jaundice Meter mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.
The single-line production capacity of Infant Transcutaneous Jaundice Meter varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.
The core drivers of the development of the transcutaneous bilirubin meter industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.
In 2024, global Infant Transcutaneous Jaundice Meter reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.
Infant Transcutaneous Jaundice Meter are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.
Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.
The upstream core components of Infant Transcutaneous Jaundice Meter mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.
The single-line production capacity of Infant Transcutaneous Jaundice Meter varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.
LP Information, Inc. (LPI) ' newest research report, the “Infant Transcutaneous Jaundice Meter Industry Forecast” looks at past sales and reviews total world Infant Transcutaneous Jaundice Meter sales in 2025, providing a comprehensive analysis by region and market sector of projected Infant Transcutaneous Jaundice Meter sales for 2026 through 2032. With Infant Transcutaneous Jaundice Meter sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infant Transcutaneous Jaundice Meter industry.
This Insight Report provides a comprehensive analysis of the global Infant Transcutaneous Jaundice Meter landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infant Transcutaneous Jaundice Meter portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infant Transcutaneous Jaundice Meter market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infant Transcutaneous Jaundice Meter and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infant Transcutaneous Jaundice Meter.
This report presents a comprehensive overview, market shares, and growth opportunities of Infant Transcutaneous Jaundice Meter market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Standard Type
Intelligent Type
Segmentation by Power Supply:
Rechargeable Type
Non-rechargeable Type
Segmentation by Technology:
Single Measurement Optical Path
Dual Measurement Optical Path
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Dräger
Mennen Medical
Philips
Konica Minolta
Beijing M&B Electronic Instruments
Ningbo David Medical Device
VECH MEDICAL
AVI Healthcare
NEORUBIN (RECOVE GROUP)
Dolphin Nanjing electronics
Heal Force
BIOBASE GROUP
Micro Lab
Key Questions Addressed in this Report
What is the 10-year outlook for the global Infant Transcutaneous Jaundice Meter market?
What factors are driving Infant Transcutaneous Jaundice Meter market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infant Transcutaneous Jaundice Meter market opportunities vary by end market size?
How does Infant Transcutaneous Jaundice Meter break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The core drivers of the development of the transcutaneous bilirubin meter industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.
In 2024, global Infant Transcutaneous Jaundice Meter reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.
Infant Transcutaneous Jaundice Meter are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.
Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.
The upstream core components of Infant Transcutaneous Jaundice Meter mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.
The single-line production capacity of Infant Transcutaneous Jaundice Meter varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.
The core drivers of the development of the transcutaneous bilirubin meter industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.
In 2024, global Infant Transcutaneous Jaundice Meter reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.
Infant Transcutaneous Jaundice Meter are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.
Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.
The upstream core components of Infant Transcutaneous Jaundice Meter mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.
The single-line production capacity of Infant Transcutaneous Jaundice Meter varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.
LP Information, Inc. (LPI) ' newest research report, the “Infant Transcutaneous Jaundice Meter Industry Forecast” looks at past sales and reviews total world Infant Transcutaneous Jaundice Meter sales in 2025, providing a comprehensive analysis by region and market sector of projected Infant Transcutaneous Jaundice Meter sales for 2026 through 2032. With Infant Transcutaneous Jaundice Meter sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infant Transcutaneous Jaundice Meter industry.
This Insight Report provides a comprehensive analysis of the global Infant Transcutaneous Jaundice Meter landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infant Transcutaneous Jaundice Meter portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infant Transcutaneous Jaundice Meter market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infant Transcutaneous Jaundice Meter and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infant Transcutaneous Jaundice Meter.
This report presents a comprehensive overview, market shares, and growth opportunities of Infant Transcutaneous Jaundice Meter market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Standard Type
Intelligent Type
Segmentation by Power Supply:
Rechargeable Type
Non-rechargeable Type
Segmentation by Technology:
Single Measurement Optical Path
Dual Measurement Optical Path
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Dräger
Mennen Medical
Philips
Konica Minolta
Beijing M&B Electronic Instruments
Ningbo David Medical Device
VECH MEDICAL
AVI Healthcare
NEORUBIN (RECOVE GROUP)
Dolphin Nanjing electronics
Heal Force
BIOBASE GROUP
Micro Lab
Key Questions Addressed in this Report
What is the 10-year outlook for the global Infant Transcutaneous Jaundice Meter market?
What factors are driving Infant Transcutaneous Jaundice Meter market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infant Transcutaneous Jaundice Meter market opportunities vary by end market size?
How does Infant Transcutaneous Jaundice Meter break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
110 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Infant Transcutaneous Jaundice Meter by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Infant Transcutaneous Jaundice Meter by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
